Tissue Sealant Impact on Skull Base Reconstruction Outcomes: A Systematic Review and Meta‐Analysis
Jonathan C. Pang,Benjamin F. Bitner,Madeline M. Nottoli,Arash Abiri,Anh‐Tram Bui,Cecilia H. Nguyen,Timothy I. Hsu,Theodore V. Nguyen,Frank P.K. Hsu,Edward C. Kuan
DOI: https://doi.org/10.1002/lary.31390
IF: 2.97
2024-03-13
The Laryngoscope
Abstract:Pairwise and network meta‐analyses of 27 non‐randomized studies revealed that use of tissue sealants (i.e., dural sealants and fibrin glues) in skull base reconstruction following the endoscopic endonasal approach may not significantly reduce risk of postoperative cerebrospinal fluid leakage either in absolute comparisons with nonuse or relative comparisons among tissue sealant types and brands. Further investigation of prospective randomized design may be warranted to thoroughly elucidate the clinical value of adjunct sealants in endoscopic skull base surgery. Objective Despite significant advances in understanding of skull base reconstruction principles, the role of tissue sealants in modifying postoperative cerebrospinal fluid (CSF) leak outcomes remains controversial. We evaluate postoperative CSF leak incidence associated with tissue sealant use in skull base defect repair during endoscopic skull base surgery (ESBS). Data Sources Web of Science, PubMed/MEDLINE, Scopus, and Cochrane Library. Review Methods Systematic review and meta‐analysis of risk differences (RD). A search strategy identified original studies reporting CSF leakage following ESBS with disaggregation by tissue sealant use and/or type. Results 27 non‐randomized studies (n = 2,403) were included for qualitative and meta‐analysis. Reconstruction with a tissue sealant did not significantly reduce postoperative CSF leak risk compared with reconstruction without sealant (RD[95% CI] = 0.02[−0.01, 0.05]). Sub‐analyses of dural sealant (−0.02[−0.11, 0.07]) and fibrin glue (0.00[−0.07, 0.07]) compared with no sealant were similarly unremarkable. Postoperative CSF leakage was not significantly modulated in further sub‐analyses of DuraSeal (0.02[−0.02, 0.05]), Adherus (−0.03[−0.08, 0.03]), or Bioglue (−0.06[−0.23, 0.12]) versus no dural sealant use, or Tisseel/Tissucol versus fibrin glue nonuse (0.00[−0.05, 0.05]). No significant association was seen comparing dural sealant use versus fibrin glue use on pairwise (0.01[−0.03, 0.05]) or network meta‐analysis (−0.01[−0.05, 0.04]). Limitations in source literature prevented sub‐analyses stratified by leak characteristics, defect size and location, and accompanying reconstruction materials. Conclusion Tissue sealant use did not appear to impact postoperative CSF leak incidence when compared with nonuse. Higher quality studies are warranted to thoroughly elucidate the clinical value of adjunct sealant use in endoscopic skull base reconstruction. Level of Evidence N/A Laryngoscope, 2024
medicine, research & experimental,otorhinolaryngology